Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gibb

Showing results (181-190 of 208) with videos related to

Pageof 21
Sort By:
Oncotarget|September 9, 2017
Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patientsMohammed Alshalalfa, Gerald W Verhaegh, Ewan A Gibb, et al.
British Journal of Haematology|October 17, 2023
Improved outcomes of large B-cell lymphoma patients treated with CD19 CAR T in the UK over timeS Boyle, C Roddie, M O'Reilly, et al.
Nature Communications|November 12, 2017
The North American bullfrog draft genome provides insight into hormonal regulation of long noncoding RNAS Austin Hammond, René L Warren, Benjamin P Vandervalk, et al.
Journal of Molecular and Cellular Cardiology|July 12, 2025
Pyruvate kinase splice variants in fibroblasts influence cardiac remodeling after myocardial infarction in male miceCollin K Wells, Daniel C Nguyen, Robert E Brainard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2023
Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder CancerSophia C Kamran, Yuzhen Zhou, Keisuke Otani, et al.
European Urology|March 14, 2020
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder CancerAndrea Necchi, Daniele Raggi, Andrea Gallina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2018
Clinical and Genomic Implications of Luminal and Basal Subtypes Across CarcinomasShuang G Zhao, William S Chen, Rajdeep Das, et al.
Circulation Research|October 23, 2020
Interaction of the Joining Region in Junctophilin-2 With the L-Type Ca<sup>2+</sup> Channel Is Pivotal for Cardiac Dyad Assembly and Intracellular Ca<sup>2+</sup> DynamicsPolina Gross, Jaslyn Johnson, Carlos M Romero, et al.
Genome Medicine|October 18, 2019
Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosisJoep J de Jong, Yang Liu, A Gordon Robertson, et al.
European Urology Oncology|March 25, 2020
Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific DifferencesJoep J de Jong, Joost L Boormans, Bas W G van Rhijn, et al.
Pageof 21

Showing results (181-190 of 208) with videos related to

Sort By:
Pageof 21
Oncotarget|September 9, 2017
Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patientsMohammed Alshalalfa, Gerald W Verhaegh, Ewan A Gibb, et al.
British Journal of Haematology|October 17, 2023
Improved outcomes of large B-cell lymphoma patients treated with CD19 CAR T in the UK over timeS Boyle, C Roddie, M O'Reilly, et al.
Nature Communications|November 12, 2017
The North American bullfrog draft genome provides insight into hormonal regulation of long noncoding RNAS Austin Hammond, René L Warren, Benjamin P Vandervalk, et al.
Journal of Molecular and Cellular Cardiology|July 12, 2025
Pyruvate kinase splice variants in fibroblasts influence cardiac remodeling after myocardial infarction in male miceCollin K Wells, Daniel C Nguyen, Robert E Brainard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2023
Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder CancerSophia C Kamran, Yuzhen Zhou, Keisuke Otani, et al.
European Urology|March 14, 2020
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder CancerAndrea Necchi, Daniele Raggi, Andrea Gallina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2018
Clinical and Genomic Implications of Luminal and Basal Subtypes Across CarcinomasShuang G Zhao, William S Chen, Rajdeep Das, et al.
Circulation Research|October 23, 2020
Interaction of the Joining Region in Junctophilin-2 With the L-Type Ca<sup>2+</sup> Channel Is Pivotal for Cardiac Dyad Assembly and Intracellular Ca<sup>2+</sup> DynamicsPolina Gross, Jaslyn Johnson, Carlos M Romero, et al.
Genome Medicine|October 18, 2019
Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosisJoep J de Jong, Yang Liu, A Gordon Robertson, et al.
European Urology Oncology|March 25, 2020
Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific DifferencesJoep J de Jong, Joost L Boormans, Bas W G van Rhijn, et al.
Pageof 21